1-anilino-8-naphthalenesulfonate has been researched along with Colorectal Neoplasms in 6 studies
1-anilino-8-naphthalenesulfonate: RN given refers to parent cpd
8-anilinonaphthalene-1-sulfonic acid : A naphthalenesulfonic acid that is naphthalene-1-sulfonic acid substituted by a phenylamino group at position 8.
Colorectal Neoplasms: Tumors or cancer of the COLON or the RECTUM or both. Risk factors for colorectal cancer include chronic ULCERATIVE COLITIS; FAMILIAL POLYPOSIS COLI; exposure to ASBESTOS; and irradiation of the CERVIX UTERI.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Yin, H | 1 |
| Li, W | 1 |
| Mo, L | 1 |
| Deng, S | 1 |
| Lin, W | 1 |
| Ma, C | 1 |
| Luo, Z | 1 |
| Luo, C | 1 |
| Hong, H | 1 |
| Mamdooh, N | 1 |
| Kasabri, V | 1 |
| Al-Hiari, Y | 1 |
| Almasri, I | 1 |
| Al-Alawi, S | 1 |
| Bustanji, Y | 1 |
| Crous-Bou, M | 1 |
| Rennert, G | 1 |
| Salazar, R | 1 |
| Rodriguez-Moranta, F | 1 |
| Rennert, HS | 1 |
| Lejbkowicz, F | 1 |
| Kopelovich, L | 1 |
| Lipkin, SM | 1 |
| Gruber, SB | 1 |
| Moreno, V | 1 |
| Fahmueller, YN | 1 |
| Nagel, D | 1 |
| Hoffmann, RT | 1 |
| Tatsch, K | 1 |
| Jakobs, T | 1 |
| Stieber, P | 1 |
| Holdenrieder, S | 1 |
| Cheong, I | 1 |
| Huang, X | 1 |
| Bettegowda, C | 1 |
| Diaz, LA | 1 |
| Kinzler, KW | 1 |
| Zhou, S | 1 |
| Vogelstein, B | 1 |
| Diani, G | 1 |
| Poma, G | 1 |
| Novazzi, F | 1 |
| Zanirato, S | 1 |
| Porta, C | 1 |
| Moroni, M | 1 |
| Melzi d'Eril, GV | 1 |
| Moratti, R | 1 |
6 other studies available for 1-anilino-8-naphthalenesulfonate and Colorectal Neoplasms
| Article | Year |
|---|---|
Adipose triglyceride lipase promotes the proliferation of colorectal cancer cells via enhancing the lipolytic pathway.
Topics: Animals; Apoptosis; Biomarkers, Tumor; Cell Proliferation; Colorectal Neoplasms; Female; Gene Expres | 2021 |
Evaluation of selected commercial pharmacotherapeutic drugs as potential pancreatic lipase inhibitors and antiproliferative compounds.
Topics: Antineoplastic Agents; Biphenyl Compounds; Cell Line, Tumor; Cell Proliferation; Colorectal Neoplasm | 2019 |
Genetic polymorphisms in fatty acid metabolism genes and colorectal cancer.
Topics: Aged; Body Mass Index; Case-Control Studies; Colorectal Neoplasms; Fatty Acids; Female; Genetic Pred | 2012 |
Immunogenic cell death biomarkers HMGB1, RAGE, and DNAse indicate response to radioembolization therapy and prognosis in colorectal cancer patients.
Topics: Adult; Aged; Alkaline Phosphatase; Amylases; Analysis of Variance; Antigens, Neoplasm; Apoptosis; Bi | 2013 |
A bacterial protein enhances the release and efficacy of liposomal cancer drugs.
Topics: Amino Acid Sequence; Animals; Antineoplastic Agents; Bacterial Proteins; Base Sequence; Camptothecin | 2006 |
Increased serum lipase with associated normoamylasemia in cancer patients.
Topics: Adenocarcinoma; alpha-Amylases; Carcinoma, Hepatocellular; Clinical Enzyme Tests; Colorectal Neoplas | 1998 |